On December 6, Yu Xubo, Chairman and Secretary of the Secretary of the Leading Party Members Group of Genertec Group, accompanied by Yao Jianhong, Vice General Manager and Member of the Leading Party Member Group, conducted a research visit to Meheco's Sanyang Pharmaceutical. The delegation toured key facilities, including the 602 Workshop, K201 Workshop, and the Pharmaceutical Research Institute. They received comprehensive briefings on Sanyang Pharmaceutical's overall operations, business performance, and key initiatives, as well as updates on the progress and direction of the Meheco Innovation Drug and Equipment Commercialization Center. This visit culminated in engaging discussions focused on the high-quality development of businesses.

Yu Xubo commended Sanyang Pharmaceutical for its notable achievements in quality control, the establishment of a production-education-research system, marketing transformation, and effective Party-building initiatives. He emphasized the need for strict adherence to the "First Topic" system and the requirements for comprehensive, strict Party governance, urging the establishment of a people-centered development philosophy that would provide both political assurance and organizational support for the company's reform and growth. Furthermore, he highlighted the importance of benchmarking against industry leaders, promoting the construction of new quality productive forces, and achieving high-value creation. Yu stressed the necessity of continuously enhancing compliance management and safety and environmental standards, advocating for the development of robust systems and processes to ensure that the company operates steadily within legal, compliant, safe, and environmentally friendly parameters. He also called for strengthening team and talent development by providing more opportunities for outstanding talents, thereby invigorating their innovative capacities. As the year-end approaches, he reiterated the critical importance of maintaining stringent work safety standards to ensure employee safety.

Yao Jianhong acknowledged the positive developmental momentum of Sanyang Pharmaceutical and outlined specific requirements for enhancing collaborative efforts within the organization.

The delegation included Xia Qi, Director of the Group Office; Wang Yun, General Manager of the Collaborative Development Department; Feng Chi, Deputy General Manager of the Strategic Department; and Yang Guang, Chairman of Meheco.